Protagonist Therapeutics (PTGX) Times Interest Earned (2015 - 2025)
Protagonist Therapeutics (PTGX) posted Times Interest Earned of -$0.1 for Q4 2025, down 100.07% sequentially from $150.75 in Q4 2024, and down 100.07% YoY from $150.75 in Q4 2024.
Protagonist Therapeutics (PTGX) Times Interest Earned (2015 - 2025) Analysis & Trends
Protagonist Therapeutics has reported Times Interest Earned for 11 years, with the latest figure at -$0.1 in Q4 2025.
- Quarterly Times Interest Earned fell 100.07% year-over-year to -$0.1 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$0.32 (down 100.07% YoY) and the FY2025 annual result came in at -$0.32, down 119.08% from the prior year.
- Times Interest Earned fell to -$0.1 in Q4 2025 per PTGX's latest filing, from $150.75 in the prior quarter.
- Over five years, Times Interest Earned peaked at $296.42 in Q1 2024 and troughed at -$55.3 in Q3 2023.
- A 5-year average of $16.04 and a median of -$0.57 in 2023 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2022 and 2024: Times Interest Earned plunged 13564.51% in 2022, then jumped 52190.3% in 2024.
- Over 5 years, Times Interest Earned stood at $31.03 in 2021, then sank by 274.35% to -$54.1 in 2022, then jumped by 74.13% to -$13.99 in 2023, then soared by 1177.2% to $150.75 in 2024, then slumped by 100.07% to -$0.1 in 2025.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$0.1, $150.75, and -$21.6 for Q4 2025, Q4 2024, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Protagonist Therapeutics | 10.03 Bn | 10.03 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.10 |
| Dec 31, 2024 | 150.75 |
| Sep 30, 2024 | -21.60 |
| Jun 30, 2024 | -18.73 |
| Mar 31, 2024 | 296.42 |
| Dec 31, 2023 | -13.99 |
| Sep 30, 2023 | -55.30 |
| Jun 30, 2023 | -0.46 |
| Mar 31, 2023 | -0.57 |
| Dec 31, 2022 | -54.10 |
| Sep 30, 2022 | -14.04 |
| Jun 30, 2022 | -24.38 |
| Mar 31, 2022 | -0.46 |
| Dec 31, 2021 | 31.03 |
| Sep 30, 2021 | -1.23 |
| Jun 30, 2021 | -0.18 |
| Mar 31, 2021 | -0.36 |
| Dec 31, 2020 | -148.27 |
| Sep 30, 2020 | -0.20 |
| Jun 30, 2020 | -0.56 |